Background: argon plasma coagulation (APC) is the current endoscopic treatment of choice for patients who develop chronic radiation proctopathy. The aim of this study was to identify risk factors associated with treatment failure.
Methods: one hundred and ninety-nine patients treated with argon plasma coagulation in a single center were retrospectively analyzed.